|
Non-obstructive azoospermia
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutation in TDRD9 causes non-obstructive azoospermia in infertile men.
|
28536242 |
2017 |
|
Azoospermia
|
0.110 |
AlteredExpression
|
disease |
BEFREE |
Impaired expression of the DDX4, MAEL,MOV10L1, PIWIL2, PIWIL4, and TDRD9 genes in the group of cryptorchid boys at high risk of infertility indicates that gene instability induced by impaired expression of transposon silencing genes contribute to the development of azoospermia.
|
22223142 |
2011 |
|
Azoospermia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
|
Non-obstructive azoospermia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
|
Small testicle
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Increased circulating gonadotropin level
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Cryptozoospermia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
|
Obstructive azoospermia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
|
Malignant neoplasm of breast
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We examined the psychometric properties, particularly the factorial validity, of the HLS-EU-Q in women with breast cancer.
|
28221213 |
2019 |
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
There were 33 items included in the C-HLS for validation; 360 newly diagnosed cancer patients completed the survey.
|
30998604 |
2019 |
|
Cerebral Palsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
This retrospective cohort study included 87 ambulatory children with CP who underwent HLS surgery with both preoperative and postoperative gait analysis (mean time, 29.4±19.9 mo after surgery) testing between 1997 and 2015.
|
31305380 |
2019 |
|
Hypertensive disease
|
0.010 |
Biomarker
|
group |
BEFREE |
Among the components of the score, BMI was apparently the main factor driving the association between the HLS and lower risk of hypertension.
|
30902699 |
2019 |
|
Retinal Vein Occlusion
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This cross-sectional questionnaire study used the validated HLS-EU-Q16 questionnaire to determine the health literacy of 225 patients with age-related macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO), receiving intravitreal treatment at the retinal clinic, Zealand University Hospital, Denmark.
|
31395040 |
2019 |
|
Age related macular degeneration
|
0.010 |
Biomarker
|
disease |
BEFREE |
This cross-sectional questionnaire study used the validated HLS-EU-Q16 questionnaire to determine the health literacy of 225 patients with age-related macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO), receiving intravitreal treatment at the retinal clinic, Zealand University Hospital, Denmark.
|
31395040 |
2019 |
|
Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We examined the psychometric properties, particularly the factorial validity, of the HLS-EU-Q in women with breast cancer.
|
28221213 |
2019 |
|
Diabetic macular edema
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This cross-sectional questionnaire study used the validated HLS-EU-Q16 questionnaire to determine the health literacy of 225 patients with age-related macular degeneration (AMD), diabetic macular edema (DME) or retinal vein occlusion (RVO), receiving intravitreal treatment at the retinal clinic, Zealand University Hospital, Denmark.
|
31395040 |
2019 |
|
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
There were 33 items included in the C-HLS for validation; 360 newly diagnosed cancer patients completed the survey.
|
30998604 |
2019 |
|
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Intranasal delivery of HLS-3 with better pharmacokinetics and pharmacodynamics performances provides a promising approach for treatment of Alzheimer's disease.
|
29966606 |
2018 |
|
Arteriosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Among the 3 components of the HLS , abstinence from smoking had the strongest association with subclinical atherosclerosis.
|
30482079 |
2018 |
|
Atherosclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Among the 3 components of the HLS , abstinence from smoking had the strongest association with subclinical atherosclerosis.
|
30482079 |
2018 |
|
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Thus, our results place TDRD9 as a marker for prognosis and as a potential therapeutic target in a subset of lung carcinomas.
|
29515758 |
2018 |
|
Adenocarcinoma of lung (disorder)
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, <i>TDRD9</i> expression is associated with poor prognosis in lung adenocarcinoma.
|
29515758 |
2018 |
|
Color Blindness, Blue
|
0.010 |
Biomarker
|
disease |
BEFREE |
Compared with the HLS + CBT control condition, the ERT + CBT condition demonstrated higher abstinence rates at 2 months (ERT + CBT = 23% vs. HLS + CBT = 0%, OR = 13.51; 95% CI = 0.70-261.59) and 4 months (ERT = 18% vs. HLS = 5%; OR = 2.98; 95% CI = 0.39-22.72) post-quit.
|
28403472 |
2017 |
|
Azoospermia, Nonobstructive
|
0.010 |
Biomarker
|
disease |
BEFREE |
To this end, five single-nucleotide polymorphisms (SNPs) in the ASZ1, PIWIL1, TDRD1, and TDRD9 genes were genotyped by TaqMan allelic discrimination assays in 342 cases of nonobstructive azoospermia (NOA) and 493 controls.
|
27233649 |
2016 |
|
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Although microsurgery has considerably improved post-operative results, multifocal tumour development and recurrence remain a serious problem in the clinical management of HLS gene carriers.
|
1431953 |
1992 |